Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

Khalid Bajou; Agnès Noël; Robert D. Gerard; Véronique Masson; Nils Brünner; Claus Holst‐Hansen; Mihaela Skobe; Norbert E. Fusenig; Peter Carmeliet; D Collen; J.M. Foidart

doi:10.1038/nm0898-923

Related publications

Article1999

Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1

Agnès Noël, Khalid Bajou, Véronique Masson, Laetitia Devy, Françis Frankenne, Jean‐Marie Rakic, Véronique Lambert, Peter Carmeliet, Jean‐Michel Foidart

Article2006

Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization

Maud Jost, Catherine Maillard, Vincent Lambert, Marc Tjwa, Pierre Blaise, Julie Lecomte, Khalid Bajou, Silvia Blacher, Patrick Motté, Chantal Humblet, Marie Paule Defresne, Marc Thiry, Françis Frankenne, André Gothot, Peter Carmeliet, Jean‐Marie Rakic, Jean‐Michel Foidart, Agnès Noël

Article2001

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

Khalid Bajou, Véronique Masson, Robert D. Gerard, Petra M. Schmitt, Valérie Albert, Michael Praus, Leif R. Lund, Thomas Leth Frandsen, Nils Brünner, Keld Danø, Norbert E. Fusenig, Ulrich H. Weidle, Geert Carmeliet, David J. Loskutoff, D Collen, Peter Carmeliet, Jean‐Michel Foidart, Agnès Noël

Article2005

Host Plasminogen Activator Inhibitor-1 Promotes Human Skin Carcinoma Progression in a Stage-Dependent Manner

Catherine Maillard, Maud Jost, Maria Unni Rømer, Nils Brünner, Xavier Houard, Annabelle Lejeune, Carine Munaut, Khalid Bajou, Laurence Mélen, Keld Danø, Peter Carmeliet, Norbert E. Fusenig, Jean Michel Foidart, Agnès Noël

Article2004

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Khalid Bajou, Catherine Maillard, Maud Jost, Roger Lijnen, Ann Gils, Paul Declerck, Peter Carmeliet, Jean-Michel Foidart, Agnès Noël